LEWIS JOEL bought GALT
November 3, 2025 · Form 4 insider transaction
LEWIS JOEL bought 1,300 shares of Galectin Therapeutics Inc. at $2.39 per share, a transaction worth $3.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,300
Price
$2.39
Total value
$3.1K
InsiderLEWIS JOEL
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 3, 2025
Filing dateNovember 5, 2025
Shares owned after833,892
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.